Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹152 Cr₹163 Cr₹170 Cr₹84 Cr₹88 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA is ₹152 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹152 Cr
Mar2025₹163 Cr
Mar2024₹170 Cr
Mar2023₹84 Cr
Mar2022₹88 Cr

How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹152 Cr
-6.56
Mar2025 ₹163 Cr
-4.09
Mar2024 ₹170 Cr
101.52
Mar2023 ₹84 Cr
-4.05
Mar2022 ₹88 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,527.4 Cr -1.7% -1.5% 57.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,278.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹243,966.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹109,950.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹95,967.4 Cr 1.4% -3.7% -8.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.7%

-1.5%

57.8%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses